-
1 Comment
Primo Nutraceuticals Inc is currently in a long term uptrend where the price is trading 36.7% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Primo Nutraceuticals Inc gets an overall score of 2/5.
Industry | Drug Manufacturers - Specialty & Generic |
---|---|
Exchange | F |
CurrencyCode | EUR |
Sector | Healthcare |
ISIN | None |
PE Ratio | None |
---|---|
Beta | 0.14 |
Market Cap | 550K |
Target Price | None |
Dividend Yield | None |
Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8BV1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025